New Novartis Corporation CEO Targets Vaccines, Generics Buys

Reuters -- Joe Jimenez, the new chief executive of Swiss drugmaker Novartis (NOVN.VX), is targeting bolt-on acquisitions as the group digests the multibillion dollar acquisition of eyecare group Alcon (ACL.N).

MORE ON THIS TOPIC